It is concerning that CSTD adoption rates for drug administration remained flat again this year despite the USP <800> requirement that CSTDs be used in this situation. Because pharmacy drives CSTD purchasing across the facility, implementing these devices for drug administration must become a more urgent priority for pharmacy. Regulatory compliance and safe practice necessitate that pharmacy provides this protection for nursing.
For 3 years, there has been no growth in the number of facilities with CSTDs in place for HD administration. Pharmacy must prioritize CSTD acquisitions to provide adequate protection for the nursing staff.
While there is room for improvement of CSTD adoption rates among facilities of all sizes, those hospitals with fewer than 100 beds have been the slowest to provide this protection to their nursing staff.
Rarely are CSTDs adopted in the hospital without the input of pharmacy; as such, pharmacy must take a leadership role in ensuring this technology is available for all staff administering HDs.
A variety of CSTDs are currently in use across this marketplace.
User satisfaction remains high among nurses; 99% are satisfied with their CSTD vendor of choice.
For drug administration, the leading vendors are BD, Equashield, B. Braun, and ICU Medical, followed by Baxter.
For those facilities looking to adopt CSTDs for the first time or to switch to a new vendor, Equashield, BD, B. Braun, and ICU lead the vendors under consideration.
Like what you've read? Please log in or create a free account to enjoy more of what www.pppmag.com has to offer.